PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 176 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,833 | -30.0% | 19,740 | +11.4% | 0.00% | -50.0% |
| Q2 2023 | $235,588 | +52.8% | 17,713 | +33.1% | 0.00% | +100.0% |
| Q1 2023 | $154,144 | +146703.8% | 13,311 | +3.9% | 0.00% | – |
| Q4 2022 | $105 | -99.9% | 12,811 | -6.6% | 0.00% | -100.0% |
| Q3 2022 | $80,000 | +19.4% | 13,711 | -9.6% | 0.00% | 0.0% |
| Q2 2022 | $67,000 | -62.4% | 15,169 | -22.4% | 0.00% | 0.0% |
| Q1 2022 | $178,000 | -55.4% | 19,546 | +0.3% | 0.00% | -66.7% |
| Q4 2021 | $399,000 | -3.6% | 19,487 | +20.4% | 0.00% | 0.0% |
| Q3 2021 | $414,000 | -28.6% | 16,187 | -2.4% | 0.00% | -40.0% |
| Q2 2021 | $580,000 | -0.2% | 16,587 | -4.9% | 0.01% | -16.7% |
| Q1 2021 | $581,000 | +50.5% | 17,438 | +17.1% | 0.01% | +50.0% |
| Q4 2020 | $386,000 | +173.8% | 14,886 | +4.0% | 0.00% | +100.0% |
| Q3 2020 | $141,000 | +513.0% | 14,320 | +118.1% | 0.00% | – |
| Q2 2020 | $23,000 | -55.8% | 6,565 | -34.4% | 0.00% | -100.0% |
| Q3 2019 | $52,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WATER ISLAND CAPITAL LLC | 4,718,964 | $24,255,000 | 1.69% |
| HighVista Strategies LLC | 378,479 | $1,945,000 | 1.48% |
| Exane Asset Management | 198,743 | $1,021,539,000 | 1.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,110,666 | $5,709,000 | 1.07% |
| BOURNE LENT ASSET MANAGEMENT INC | 441,650 | $2,270,000 | 1.07% |
| Versor Investments LP | 3,148,691 | $16,184,000 | 0.82% |
| Magnetar Financial LLC | 6,919,655 | $35,567,000 | 0.74% |
| AQR Arbitrage LLC | 6,953,621 | $35,742,000 | 0.60% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 915,124 | $4,704,000 | 0.54% |
| Bellevue Group AG | 5,734,309 | $29,474,000 | 0.47% |